Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MPM Raises $400m To Build Early-Stage Biotechs

Feb 21 2019

• By Kevin Grogan

Jump — MPM aims to support biotechs through every step of development • Source: Shutterstock

Related Content

Astellas Exercises Option To Acquire Potenza, For Up To $405m

Dec 14 2018

Related Companies

Harpoon Therapeutics

TCR² Therapeutics Inc.

Amgen, Inc.

Astellas Pharma, Inc.

Mitobridge, Inc.

Gilead Sciences, Inc.

Pharmasset, Inc.

Additional Topics

Financing ImmunoOncology Business Strategies Commercial Cancer BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window